Page 5 of articles about vaccine in Press releases

The product is a live bacterial vaccine containing a combination of two non-pathogenic E. coli strains for active immunization of pigs against PWD.

Boehringer Ingelheim, KMOH, and ZNWT establish a vaccine joint venture targeting foot-and-mouth disease control and prevention in China.

On 19th October last, Hipra launched the new VEPURED® vaccine against edema disease. The event, which took place in Germany, was attended by over 200 specialist veterinarians from Europe and Russia.

In less than a year, University of Saskatchewan (U of S) scientists have developed and tested a prototype vaccine that could protect the North American swine industry from a virus that has killed more than eight million pigs and cost more than $400 million in lost income since 2013.

Experts meet in Barcelona to discuss new strategies to prevent the disease.

New vaccines Ingelvac PRRSFLEX® EU for piglets and ReproCyc® PRRS EU for sows offer sustainable control of Porcine Reproductive and Respiratory Syndrome (PRRS).

Veterinarians and farmers across the globe have reached the landmark of protecting one billion pigs from the potentially devastating effects of Porcine Circovirus Disease (PCVD) using Ingelvac CircoFLEX®

Ecoporc Shiga induces a high level of immunity against shigatoxin, produced by E coli bacteria which cause edema.

As flu season swings into full gear, producers and those who work with pigs are reminded that it’s not too late to get a seasonal flu vaccination.

The U.S. Department of Homeland Security has awarded Harrisvaccines a $1 million-plus contract to develop a vaccine for foot-and-mouth disease, one of the world’s most economically devastating animal diseases.

A vaccine program can help prevent many potential problems for producers. However, if vaccines aren't stored and handled correctly, the program can be ineffective.

Virbac has entered into a new strategic alliance in food-producing animals vaccines, by setting up a joint-venture with the Taiwanese company Schweitzer Biotech Company (SBC).

Mycoplasmal pneumonia and porcine circovirus are two of the costliest diseases affecting pork producers. Helping provide protection before disease exposure is critical to the success of any vaccination program.

Merck Animal Health (known as MSD Animal Health outside the USA and Canada) today announced that it has received marketing authorization in the European Union for PORCILIS® M Hyo ID ONCE, the first single-shot vaccine against Mycoplasma hyopneumoniae (M Hyo) infection in pigs for intradermal administration.